Online citations, reference lists, and bibliographies.
← Back to Search

Antibody Response To Paramyxoviruses In Paget’s Disease Of Bone

M. Visconti, R. Usategui-Martín, S. Ralston
Published 2017 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Paget’s disease of bone (PDB) is a common skeletal disorder characterised by focal abnormalities of increased and disorganised bone turnover. Genetic factors play a central role in the pathogenesis of PDB but environmental factors also contribute. Measles virus (MV), respiratory syncytial virus (RSV) and canine distemper virus (CDV) have all been implicated as potential disease triggers but the data are conflicting. Since chronic paramyxovirus infection with measles is known to be accompanied by increased production of antiviral antibodies, we have analysed circulating concentrations of antibodies to MV, CDV, and RSV as well as mumps, rubella and varicella zoster virus (VZV) in 463 patients with PDB and 220 aged and gender-matched controls. We also studied the relation between viral antibody concentrations and various markers of disease severity and extent in 460 PDB patients. A high proportion of cases and controls tested positive for antiviral antibodies but there was no significant difference in circulating antibody concentrations between PDB cases and controls for MV, CDV, RSV, rubella or VZV. However, mumps virus antibody levels were significantly higher in the PDB cases (mean ± SD = 3.1 ± 0.84 vs. 2.62 ± 0.86. p < 0.001). There was no association between disease severity and circulating antibody concentrations to any of the viruses. In conclusion, we found no evidence to suggest that PDB is associated with abnormalities of immune response to measles or other paramyxoviruses, although there was evidence of a greater antibody response to mumps. The results do not support that hypothesis that PDB is associated with a persistent infection with measles or other paramyxoviruses.
This paper references
10.1148/radiographics.22.5.g02se181190
[Paget disease of bone].
H. Czickeli (1950)
10.1136/jech.28.4.226
Distribution of Paget's disease in England, Wales and Scotland and a possible relationship with vitamin D deficiency in childhood
D. Barker (1974)
Particularités ultrastructurales des ostéoclastes de la maladie de Paget
A. Rebel (1974)
10.1016/S0140-6736(74)92935-3
PRACTOLOL IN THE CONTROL OF INTRAOCULAR TENSION
A. Hagedoorn (1974)
10.32388/158288
Subacute sclerosing panencephalitis.
M. Eisengart (1976)
10.1126/SCIENCE.959849
Nuclear inclusions in Paget's disease of bone.
B. Mills (1976)
10.1016/S0140-6736(77)91132-1
MEASLES-VIRUS-SPECIFIC IMMUNOGLOBULIN-M RESPONSE IN SUBACUTE SCLEROSING PANENCEPHALITIS
W. Kiessling (1977)
Measlesvirus-specific immunoglobulin-M response in subacute sclerosing panencephalitis
WR Kiessling (1977)
10.1136/bmj.1.6168.931
Billiard-player's fingers: an unusual case of Paget's disease of bone.
L. Solomon (1979)
10.1073/PNAS.76.12.6601
Antigenic relationships between measles and canine distemper viruses: comparison of immune response in animals and humans to individual virus-specific polypeptides.
J. Stephenson (1979)
Antigenic relationships between measles and canine distemper viruses: comparison of immune response in animals and humans to individual virusspecific polypeptides
JR Stephenson (1979)
10.1099/0022-1317-50-2-231
Immunological relationships between homologous structural polypeptides of measles and canine distemper virus.
C. Orvell (1980)
Abuse of ECT.
R. Deitch (1980)
10.1016/S0140-6736(81)92019-5
MEASLES ANTIBODY IN PAGET'S DISEASE
P. Morgan-Capner (1981)
The epidemiology of Paget's disease.
D. J. Barker (1981)
10.1073/PNAS.78.2.1209
Immunohistological demonstration of respiratory syncytial virus antigens in Paget disease of bone.
B. Mills (1981)
[Paget's bone disease. Preliminary serological study].
M. Baslé (1983)
10.1097/00003086-198403000-00044
Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone.
B. Mills (1984)
10.1099/0022-1317-66-10-2103
Paramyxovirus antigens in osteoclasts from Paget's bone tissue detected by monoclonal antibodies.
M. Baslé (1985)
10.1128/jvi.53.2.684-690.1985
Sequence homology within the morbilliviruses
S. Rozenblatt (1985)
10.1016/0042-6822(86)90382-X
Conserved structures among the nucleocapsid proteins of the paramyxoviridae: complete nucleotide sequence of human parainfluenza virus type 3 NP mRNA.
A. Sánchez (1986)
10.1016/S0140-6736(86)92042-8
SEROLOGICAL EVIDENCE AGAINST ROLE FOR CANINE DISTEMPER VIRUS IN PATHOGENESIS OF PAGET'S DISEASE OF BONE
R. Hamill (1986)
10.1099/0022-1317-67-5-907
Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization.
M. Baslé (1986)
10.1099/0022-1317-67-7-1381
The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies.
H. Sheshberadaran (1986)
10.1002/JBMR.5650061115
Failure to detect paramyxovirus sequences in paget's disease of bone using the polymerase chain reaction
S. Ralston (1991)
10.1016/0046-8177(91)90057-V
Inclusion body myositis and paramyxoviruses.
M. Kallajoki (1991)
10.1016/8756-3282(91)90042-H
Canine distemper virus localised in bone cells of patients with Paget's disease.
M. Gordon (1991)
10.1016/0169-6009(92)90923-2
Canine distemper virus transcripts sequenced from pagetic bone.
M. Gordon (1992)
Canine distemper transcripts sequenced from pagetic bone
MT Gordon (1992)
Canine distemper transcripts sequenced from pagetic bone. Bone Miner 19:159–174 Antibody Response to Paramyxoviruses in Paget’s Disease of Bone
MT Gordon (1992)
10.1002/JMV.1890400409
Prevalence of canine distemper antibodies in the pagetic population
M. Gordon (1993)
10.1016/0049-0172(94)90037-X
Epidemiological aspects of Paget's disease: family history and relationship to other medical conditions.
E. Siris (1994)
10.1002/JBMR.5650090103
Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bon
M. Birch (1994)
10.1210/JCEM.80.7.7608263
Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence.
S. Reddy (1995)
10.1002/JBMR.5650111103
Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with paget disease
S. Reddy (1996)
10.1016/S8756-3282(99)00033-2
Paramyxoviruses and Paget's disease: the affirmative view.
A. Mee (1999)
10.1359/jbmr.2000.15.12.2315
A Negative Search for a Paramyxoviral Etiology of Paget's Disease of Bone: Molecular, Immunological, and Ultrastructural Studies in U.K. Patients
M. Helfrich (2000)
10.1016/S8756-3282(00)00343-4
Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone.
C. Ooi (2000)
10.1359/jbmr.2002.17.12.2290
The Pro and Con of Measles Virus in Paget's Disease: Con
B. Rima (2002)
10.1359/jbmr.2002.17.12.2293
The Pro and Con of Measles Virus in Paget's Disease: Pro
W. Friedrichs (2002)
10.1007/s00223-004-0281-z
Paget’s Disease of Bone in New Zealand: Continued Decline in Disease Severity
H. Cundy (2004)
10.1111/J.1365-2354.2005.00597.X
Scapulo-humeral Paget's sarcoma: Scottish Bone Tumour Registry experience.
H. Sharma (2005)
10.1359/jbmr.060704
Epidemiology of Paget's Disease in Europe: The Prevalence Is Decreasing
G. Poór (2006)
Clinical practice. Paget's disease of bone.
M. Whyte (2006)
10.1359/jbmr.070103
Multicenter Blinded Analysis of RT‐PCR Detection Methods for Paramyxoviruses in Relation to Paget's Disease of Bone
Stuart H Ralston (2007)
10.1210/jc.2007-1978
Failure to detect measles virus ribonucleic acid in bone cells from patients with Paget's disease.
B. Matthews (2008)
Failure to detect measles virus RNA in bone cells from patients with Paget’s disease
BG Matthews (2008)
marrow cultures from patients with Paget ’ s disease of bone
BG Matthews (2008)
10.1359/jbmr.090709
Randomized trial of intensive bisphosphonate treatment versus symptomatic management in paget's disease of bone
Anne L Langston (2010)
10.1002/jbmr.132
Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of bone
M. R. Visconti (2010)
Randomised trial of intensive bisphosphonate treatment versus symptomatic management in paget’s disease of bone
AL Langston (2010)
10.1016/j.cmet.2010.12.002
Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
N. Kurihara (2011)
10.1016/j.bone.2013.04.024
Epidemiology of Paget's disease of bone: a systematic review and meta-analysis of secular changes.
L. Corral-Gudino (2013)
10.1002/jbmr.1975
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease
O. Albagha (2013)
10.1007/s00223-014-9904-1
Clinical Presentation of Paget’s Disease: Evaluation of a Contemporary Cohort and Systematic Review
A. Tan (2014)
10.1002/jcb.25291
Biology and Treatment of Paget's Disease of Bone
Mahéva Vallet (2016)
10.1002/jbmr.3066
Long‐Term Randomized Trial of Intensive Versus Symptomatic Management in Paget's Disease of Bone: The PRISM‐EZ Study
A. Tan (2017)
Pathol Biol



This paper is referenced by
10.1007/s11882-021-01001-2
Paget’s Disease of Bone: Osteoimmunology and Osteoclast Pathology
E. Rabjohns (2021)
10.1007/s11914-021-00676-w
Genetic Determinants of Paget’s Disease of Bone
N. Makaram (2021)
10.7554/eLife.65715
Epigenetic analysis of Paget’s disease of bone identifies differentially methylated loci that predict disease status
I. Diboun (2021)
10.1101/2021.01.04.425216
Epigenetic analysis of Paget’s disease of bone identifies differentially methylated loci that predict disease status
I. Diboun (2021)
10.1016/j.bone.2020.115265
A mutation in p62 protein (p. R321C), associated to Paget's disease of bone, causes a blockade of autophagy and an activation of NF-kB pathway.
R. Usategui-Martín (2020)
10.1016/j.bone.2020.115465
Bisphosphonates in the management of Paget's disease.
S. Ralston (2020)
10.1002/jbmr.3657
Diagnosis and Management of Paget's Disease of Bone in Adults: A Clinical Guideline
S. Ralston (2019)
10.1242/dmm.035576
Zoledronic acid prevents pagetic-like lesions and accelerated bone loss in the p62P394L mouse model of Paget's disease
A. Daroszewska (2018)
10.1080/21678707.2018.1500691
Paget’s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy
L. Gennari (2018)
10.1016/j.beem.2018.05.005
Paget's disease of bone.
N. Appelman-Dijkstra (2018)
10.17816/RFD2018425-30
The defeat of the temporal bone in Paget’s disease as a cause of hearing loss in elderly and senile age
S. A. Ivanov (2018)
10.1016/J.MPORTH.2018.05.009
Paget's disease of bone
A. Fishlock (2018)
Study of RIN3 : a susceptibility gene for Paget’s disease of bone
Mahéva Vallet (2017)
Semantic Scholar Logo Some data provided by SemanticScholar